Clinical Context
A typical patient is an adult or adolescent referred by a primary care physician, genetic counselor, or obstetrician for targeted genotyping of common methylenetetrahydrofolate reductase (MTHFR) gene variants. Common clinical indications include evaluation of unexplained recurrent pregnancy loss, suspected hyperhomocysteinemia, family history of MTHFR variants, or as part of thrombophilia workup in a patient with venous thromboembolism. The workflow begins with outpatient order entry specifying 81291, collection of a peripheral blood sample or buccal swab at an ambulatory clinic or specialty practice, specimen labeling and shipment to a molecular diagnostics laboratory. The laboratory performs the technical assay to detect common MTHFR sequence changes (for example, C677T and A1298C) and generates a report of detected variants. The report is reviewed by a laboratory director or pathologist, the professional interpretation (if billed separately) is provided to the ordering clinician, and results are incorporated into the patient’s electronic health record for follow-up counseling or management by the ordering provider.
Coding Specifications
| Modifier | Description | When to Use |
|---|
26 | Professional component | Use when billing only the professional interpretation component if the laboratory separates technical and professional components. |
TC | Technical component | Use when billing only the technical component (laboratory processing) of the test. |
90 | Reference (outside) laboratory | Use when the performing laboratory refers the specimen to another lab for testing. |
59 | Distinct procedural service | Use when multiple unrelated services are provided the same day and you need to indicate distinct procedural service. |
52 | Reduced services | Use when the test is partially reduced or not fully performed. |
53 | Discontinued procedure | Use when testing is started but discontinued for documented clinical reasons. |
76 | Repeat procedure by same physician | (Not in provided list; not applicable) |
78 | Unplanned return to the operating/procedure room | Use only if applicable to procedural contexts; rarely used for this code. |
62 | Two surgeons | Use when two separate physician specialties share responsibility for a procedure; rarely applicable for lab testing. |
90 | Reference (duplicate listed) | Duplicate entry avoided in usage; already defined above. |
91 | Repeat clinical diagnostic laboratory test | (Not in provided list; not applicable) |
| Taxonomy Code | Specialty | Notes |
|---|
| 207Q00000X | Medical Genetics | Clinical geneticists who order or interpret genetic test results. |
| 2080P0208X | Hematology | Hematologists involved in thrombophilia assessment and hypercoagulable workups. |
| 207L00000X | Pathology | Pathologists and laboratory directors overseeing molecular diagnostic testing. |
| 2084P0800X | Obstetrics & Gynecology | OB/GYNs ordering testing for recurrent pregnancy loss or preconception evaluation. |
| 367A00000X | Clinical Laboratory | Clinical laboratory technologists and directors performing the assay. |
Note: From the provided modifier list, the most clinically relevant modifiers applied above are 26, TC, 90, 59, 52, and 53. Other provided modifiers are less commonly applied to this outpatient genetic test but may be used in specific administrative situations such as payer requirements or laboratory arrangements.
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|
Z13.79 | Encounter for screening for other metabolic disorders | Used when genetic screening for metabolic risk factors such as MTHFR variants is performed. |
D68.9 | Coagulation defect, unspecified | Relevant for evaluation of thrombophilia where MTHFR variants may be considered as part of workup. |
O03.9 | Spontaneous abortion, unspecified | MTHFR testing may be ordered in the context of recurrent pregnancy loss evaluation. |
O26.82 | Pregnancy care for known or suspected fetal chromosomal abnormality | Used when maternal genetic variants are evaluated during pregnancy risk assessment. |
E78.0 | Pure hypercholesterolemia | Hyperhomocysteinemia associations sometimes prompt MTHFR testing in metabolic evaluations. |
R79.89 | Other abnormal findings of blood chemistry | Ordered when abnormal laboratory markers such as elevated homocysteine prompt genetic testing. |
Z15.09 | Genetic susceptibility to other diseases | Used for documented family history or personal concern about genetic predisposition. |
These ICD-10 codes reflect common clinical contexts in which targeted MTHFR variant analysis (81291) is ordered.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
81479 | Unlisted molecular pathology procedure | Used when a more specific molecular test not listed is performed in conjunction with targeted MTHFR testing or for novel assays. |
81292 | Analysis of MTHFR gene, full gene sequencing (if available) | Performed when full sequencing is required beyond common variant detection covered by 81291. |
83890 | Molecular diagnostic procedure; genotyping by polymerase chain reaction (PCR) | Common technical method used in laboratories to detect specific single nucleotide variants such as those in MTHFR. |
80500 | Genetic testing, pharmacogenomic; analysis of single gene (if applicable) | May be performed when pharmacogenomic implications overlap with MTHFR testing in medication management contexts. |
88271 | Microbial culture or probe (example of ancillary lab codes) | Represents ancillary laboratory services that may be billed alongside molecular diagnostics in some workflows. |
If specific related CPT codes were not provided in the input, the above list represents commonly associated molecular and laboratory codes used before, during, or after targeted MTHFR variant testing in clinical practice.